In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid

Metabolite profiling of novel psychoactive substances (NPS) is critical for documenting drug consumption. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA) is an emerging synthetic cannabinoid whose toxicological and metabolic data are currently una...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlier, Jeremy, Diao, Xingxing, Wohlfarth, Ariane, Scheidweiler, Karl, Huestis, Marilyn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771045/
https://www.ncbi.nlm.nih.gov/pubmed/29403341
http://dx.doi.org/10.2174/1570159X15666161108123419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771045/
https://www.ncbi.nlm.nih.gov/pubmed/29403341
http://dx.doi.org/10.2174/1570159X15666161108123419

Ejemplares similares